Literature DB >> 10218962

Differential effects of leptin in regulation of tissue glucose utilization in vivo.

J L Wang1, N Chinookoswong, S Scully, M Qi, Z Q Shi.   

Abstract

We have recently shown that leptin enhances systemic insulin sensitivity and whole body glucose utilization in the rat. This study examines our hypothesis that leptin has differential effects in regulating glucose utilization among the tissues, i.e. stimulating glucose utilization in brown adipose tissue (BAT) and skeletal muscle but suppressing glucose utilization in white adipose tissue (WAT) in normal male rats (275-350 g BW). The rats were treated with s.c. infusion of recombinant murine leptin (4 mg/kg x day) or vehicle (V) with Alzet osmotic pumps or with vehicle and pair-feeding (PF) for 7 days. Leptin significantly decreased food intake (leptin, 11.5 +/- 0.4 g/day; V, 16.8 +/- 1.5 g/day; P < 0.05) and body weight (maximum change, 5.0 +/- 0.2%; P < 0.05 vs. V) and lowered plasma triglyceride, insulin, and glucose levels, but raised beta-hydroxybutyrate levels. Glucose utilization by individual tissues was determined with an i.v. bolus of [1-(14)C]2-deoxyglucose (2-DG) after a 90-min hyperinsulinemic (2 mU/kg x min) euglycemic clamp. With leptin treatment, the 2-DG-determined glucose utilization in interscapular BAT was almost 3-fold that in V-treated rats and 70% greater than that in PF rats. In contrast, in the epididymal WAT, glucose utilization was reduced by leptin treatment to only 34% that in V-treated rats and 45% that in PF rats. Leptin increased 2-DG uptake by extensor digitorum longus muscle and soleus muscle compared with that in the V and PF groups. With leptin treatment, the GLUT4 glucose transporter mRNA and protein levels were increased in BAT, but decreased in WAT (both P < 0.05). There was no significant change in GLUT4 mRNA and protein expression in extensor digitorum longus muscle and soleus muscle. Oxygen consumption was significantly increased (32.1 +/- 7.4%) in BAT (139.0 +/- 8.2 nmole O2/30 min x 10(6) cells) of leptin-treated rats vs. that in V control rats (105.3 +/- 6.7 nmole O2/30 min x 10(6) cells). In conclusion, leptin has differential, tissue-specific effects on glucose and oxygen utilization, which contribute to the reduction in whole body adiposity by enhancing energy consumption in BAT and muscle while attenuating energy storage in WAT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218962     DOI: 10.1210/endo.140.5.6681

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats.

Authors:  Nathan T Jenkins; Jaume Padilla; Arturo A Arce-Esquivel; David S Bayless; Jeffrey S Martin; Heather J Leidy; Frank W Booth; R Scott Rector; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2012-09-27

2.  Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome?

Authors:  Kendra K Bence
Journal:  J Clin Metab Diabetes       Date:  2010-05

Review 3.  Leptin in inflammation and autoimmunity.

Authors:  Antonio La Cava
Journal:  Cytokine       Date:  2017-10       Impact factor: 3.861

Review 4.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

5.  Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats.

Authors:  Jussara M do Carmo; John E Hall; Alexandre A da Silva
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-12       Impact factor: 4.733

Review 6.  Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.

Authors:  Satya P Kalra
Journal:  Peptides       Date:  2009-08-06       Impact factor: 3.750

7.  Adipocytokine profile and insulin resistance in childhood obesity.

Authors:  Iuliana Gherlan; Suzana Vladoiu; Florin Alexiu; Mihaela Giurcaneanu; Sabina Oros; Andreea Brehar; Camelia Procopiuc; Constantin Dumitrache
Journal:  Maedica (Buchar)       Date:  2012-09

8.  Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.

Authors:  Katherine J Motyl; Laura R McCabe
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

Review 9.  Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.

Authors:  Satya P Kalra
Journal:  Peptides       Date:  2007-10-24       Impact factor: 3.750

10.  Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues.

Authors:  Chitoku Toda; Tetsuya Shiuchi; Suni Lee; Maya Yamato-Esaki; Yusuke Fujino; Atsushi Suzuki; Shiki Okamoto; Yasuhiko Minokoshi
Journal:  Diabetes       Date:  2009-09-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.